benefits of combining cd38 inhibitor with 5-amino-1mq nad+ and combination Comment βcuriousβ for the full newsletter. π There's a new metabolic regulator making waves. In preclinical studies, it: β grip strength ~40%, β muscle size, β Immunomodulatory properties of CD38 antibodies
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma Bisht 2023 Cancer Medicine Wiley Online Library US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Nicotinamide N Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17





